Drugs & TargetsFree FDA approves sNDA for Alunbrig tablets, Takeda announces October 06, 2017Vol.43 No.37
Drugs & TargetsFree FDA grants priority review for Genentech’s Perjeta in adjuvant HER2+ early breast cancer October 06, 2017Vol.43 No.37
Drugs & TargetsFree Amgen, CytomX Therapeutics form immuno-oncology collaboration October 06, 2017Vol.43 No.37
Drugs & Targets Novartis’s Kymriah becomes first gene therapy to get FDA approval October 03, 2017Vol.40 No.08
Drugs & Targets FDA approves Verzenio for advanced or metastatic breast cancers September 29, 2017Vol.43 No.36
Drugs & Targets First anti-PD-1 therapy approved for advanced gastric adenocarcinoma September 29, 2017Vol.43 No.36
Drugs & Targets Amgen and AbbVie agree to settlement allowing commercialization of Amgevita September 29, 2017Vol.43 No.36
Drugs & Targets FDA approves new label for Sun Pharma’s Odomzo for sustained duration of response in treatment of basal cell carcinoma September 29, 2017Vol.43 No.36
Drugs & Targets EU approves AVEO’s Fotivda (tivozanib) for advanced renal cell carcinoma September 28, 2017Vol.43 No.32
